scholarly journals COVID-19's Economic Impact on the Global Health Systems: Time to Respond to New Realities

Author(s):  
Ziyad S. Almalki

Around six months have passed since the emergence of an ongoing coronavirus-related health pandemic. In resource-limited countries, healthcare systems with fewer options for intervention are likely to face more economic difficulties. The goal of this review is to summarize and explore the cost and economic effect of COVID-19 on global health systems. The study starts with a crisis synopsis and costs of COVID-19 treatment, then discusses how health has been affected and approaches to alleviating the burden while at the same time limiting an inevitable income loss. Even if it is difficult to project COVID-19 spending because there are many uncertainties about the disease and its future course, various reports have quantified the amounts spent on direct COVID-19 treatment in different countries. The healthcare sector around the world has faced catastrophic financial challenges and experienced the largest global recession in history. Most governments in the world cannot avoid the devastating economic impact of COVID-19 on the healthcare sector, but they can try to avert the worst effects. With the spread of the coronavirus, the healthcare systems are facing a financial crisis as a result of actions that countries have adopted to mitigate the spread of the virus. Therefore, it is crucial to act swiftly and in meaningful ways to minimize the fallout from this shock.

Author(s):  
Gemmechu Hasen ◽  
Rashed Edris ◽  
Gadisa Chala ◽  
Yesuneh Tefera ◽  
Hawi Hussen ◽  
...  

AbstractThe coronavirus disease 19 (COVID-19) pandemic is putting a huge strain on healthcare systems and is a turning point for the beginning of a global health crisis of an unprecedented condition. As such, the provision of quality pharmacy services particularly, dispensing practice with pre-existing challenges in resource-limited settings is a grave concern in the era of the COVID-19 pandemic. Thus, in this commentary we described the pattern of dispensing practice in the midst of the COVID-19 pandemic by evaluating the current condition of drug dispensing practice in drug retail outlets of Jimma Town.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Nazih A. Bizri ◽  
Walid Alam ◽  
Tala Mobayed ◽  
Hani Tamim ◽  
Maha Makki ◽  
...  

Abstract Background COVID-19 has hit the world in an unprecedented way causing serious repercussions on several aspects of our life. Multiple determinants have affected various nations’ level of success in their responses towards the pandemic. The Arab Levant region in the Middle East, notoriously known for repeated wars and conflicts, has been affected, similarly to other regions, by this pandemic. The combination of war, conflict, and a pandemic brings too much of a burden for any nation to handle. Methods A descriptive analysis of data obtained from the health departments of various Arab Levant Countries (ALC) was performed. ALC include Lebanon, Syria, Jordan, Iraq and Palestine. The data collected involves incidence, recovery rate, case fatality rate and number of tests performed per million population, Global Health Security index, government stringency index, and political stability index. The information obtained was compared and analyzed among the ALC and compared to global figures. An extensive electronic literature search to review all relevant articles and reports published from the region was conducted. The 2019 Global Health Security (GHS) index was obtained from the “GHS index” website which was made by John Hopkins University’s center for health security, the Nuclear threat Initiative (NTI) and the Economist Intelligence Unit (EIU). Government stringency index and political stability index were obtained from the University of Oxford and the website of “The Global Economy”, respectively. Other world governance indicators such as government effectiveness were obtained from the World Bank website. Results In terms of incidence of COVID-19, Iraq has the highest with 9665 per one million population, Syria the lowest at 256 per million. Deaths per million population was highest in Iraq at 237, and the lowest in Syria at 12. As for number of tests per million population, Lebanon ranked first at 136,033 with Iraq fourth at 59,795. There is no data available for the tests administered in Syria and subsequently no value for tests per million population. In terms of recoveries from COVID-19 per million population, Iraq had the highest number at 7903 per million, and Syria the lowest at 68 per million. When compared as percent recovery per million, Palestine ranked first (84%) and Syria last (27%). The government response stringency index shows that Jordan had the highest index (100) early in the pandemic among the other countries. Palestine’s index remained stable between 80 and 96. The other countries’ indices ranged from 50 to 85, with Lebanon seeing a drop to 24 in mid-August. Even with improved stringency index, Iraq reported an increased number of deaths. Conclusion In countries devastated by war and conflict, a pandemic such as COVID-19 can easily spread. The Arab Levant countries represent a breeding ground for pandemics given their unstable political and economic climate that has undoubtedly affected their healthcare systems. In the era of COVID-19, looking at healthcare systems as well as political determinants is needed to assess a country’s readiness towards the pandemic. The unrest in Lebanon, the uprising in Iraq, the restrictions placed on Syria, and the economic difficulties in Palestine are all examples of determinants affecting pandemic management. Jordan, on the contrary, is a good example of a stable state, able to implement proper measures. Political stability index should be used as a predictor for pandemic management capacity, and individual measures should be tailored towards countries depending on their index.


2020 ◽  
Vol 12 (2) ◽  
pp. 260-267
Author(s):  
Alicia Ely Yamin

Abstract What the world and our health systems and societies look like in the future depends on the meaning(s) we take from this pandemic, and in turn how we collectively respond. Before the pandemic, we were living in a scandalously unequal world in which one per cent owned as much wealth as the rest of the globe’s population. Worse yet, as Eduardo Galeano suggested, in our upside-down world, this injustice had come to be accepted as a law of nature. This calamity has ravaged the planet with added suffering—some from the disease itself and more that is the result of structural injustice and policies adopted in response. But the disruption in the lives of tens of millions, as well as in the organization of our societies, provides an opportunity for subverting a number of pillars of the upside-down world, and we in the overlapping fields of health justice and human rights have a responsibility to think and act boldly on transformative political possibilities now. In this essay, I set out three lessons and the implications of those lessons. First, we must hold governments to account for the disparate impacts not only of the virus but of governmental responses to the virus. Secondly, if we hope to emerge from this pandemic with meaningful social contracts, it is imperative that we understand health and health systems as integral to democracy. Thirdly, we need to reimagine the architecture of aid, as well as global health and economic governance.


Author(s):  
Divya Chaudhry ◽  
Priyanka Tomar

Pandemics have indefinitely threatened the resilience of health systems worldwide. Based on the costs inflicted by some of the deadliest pandemics in human history, economists have projected that global pandemics could cost over USD 6 trillion and generate an annual estimated loss of over USD 60 billion. While the global health community is tirelessly trying to curb the burden of premature mortality from several old and new forms of pathogens, it is now faced with the silently emerging antimicrobial resistance (AMR) pandemic that could endanger some of the most significant advances in modern medicine. Owing to rampant antibiotic consumption in India, the article shows why the country may become the ‘AMR capital of the world’. It shows how health systems may be strengthened both at the national and international levels to reduce premature mortality and morbidity attributable to AMR and pandemics. 


Author(s):  
Chris Oyewole Durojaiye ◽  
Robin Morgan

The COVID-19 crisis has brought unprecedented strain on healthcare systems around the world. It has perhaps taught us some key lessons that are worth considering and addressing to help build more sustainable health systems as well as improve our ability to combat future epidemics.


2021 ◽  
Vol 17 (3) ◽  
pp. 71-75
Author(s):  
Dariusz Soboń ◽  
Janusz Soboń ◽  
Joanna Rogozińska-Mitrut ◽  
Ruslana Seleznova

Abstract What began as a single COVID-19 case in China in late 2019 quickly spread around the globe in the first quarter of 2020. While the impact on the world’s health systems is unknown, the economic toll remains also remains unknown as the world grapples with an unprecedented global recession. This paper estimates that COVID-19 will drag African economies into a fall of about 2,1% in GDP, with smaller economies facing contraction of up to 8%. The contraction is mainly a result of export adjustments affecting primary commodity exporters, and the attendant losses to tax revenue which reduce the capacity of government to extend the public services necessary to respond to the crisis.


Author(s):  
Federico Ramos Ruiz ◽  
Amador Ernesto Macias Osuna

The world population is ageing at an accelerated pace. It is estimated there are 900 million people aged 60 years or above worldwide, and with the rise in life expectancy comes an increased prevalence of chronic diseases such as dementia. In September 2015, Alzheimer’s Disease International reported a total of 46.8 million people with dementia worldwide, which is expected to increase to 74.7 million and 135.1 million by 2030 and 2050, respectively. Dementia also has a tremendous worldwide economic impact on health systems. In 2015, the total cost of dementia care was 818 billion dollars, representing an increase of 35.4% from 2010.


2017 ◽  
Vol 3 (Suppl 1) ◽  
pp. S1-S2 ◽  
Author(s):  
Rajesh Aggarwal

Simulation has already transformed medical education, and holds the power to shape modern healthcare systems, communities and populations. Simnovate is a mission, a community and a partnership of passionate, driven and game-changing individuals, who wish to see the change we can make together, in the world, right now. Four domains were defined: patient safety, medical technologies, global health and pervasive learning, with domain group experts that span healthcare simulation, outcomes research, aviation, serious gaming, patient safety, economics, machine learning, biorobotics, implementation science, global health and the visual arts. Bringing together simulation, innovation and education, for better health and care.


2020 ◽  
Vol 11 (3) ◽  
pp. 318-340
Author(s):  
Priya Gauttam ◽  
Bawa Singh ◽  
Jaspal Kaur

Health diplomacy has remained an important part of foreign policy of major countries to expand their geopolitical influence across the world. Given the outbreak of COVID-19, the inadequate healthcare systems even of the developed countries have been exposed. Although China was blamed for the origination of COVID-19, concomitantly, the same country had exploited the global health emergency by putting its global health diplomacy in practice as a soft power tool to expand its geopolitical influence in term of hegemony, vis-→-vis the USA. Whereas, on the contrary, the USA and European Union (EU) have been critically entrapped in the pandemic and remained at crossroads, how to deal with the same locally and globally. In these contrasting roles and reciprocation, the main argument of the article is that China had made the best use of its health diplomacy to expand its geopolitical influence, while the USA and EU did not rise to the occasion; rather, their roles and reciprocation have remained delayed and inert. In this backdrop, the main focus of this article is to examine how China used its global health diplomacy as a soft power tool? Second, would China become hegemon in the present scenario vis-→-vis the USA?


Author(s):  
Albert A. Okunade ◽  
Ahmad Reshad Osmani

Healthcare cost encompasses expenditures on the totality of scarce resources (implicit and explicit) given up (or allocated) to produce healthcare goods (e.g., drugs and medical devices) and services (e.g., hospital care and physician office services are major components). Healthcare cost accounting components (sources and uses of funds) tend to differ but can be similar enough across most of the world countries. The healthcare cost concept usually differs for consumers, politicians and health policy decision-makers, health insurers, employers, and the government. All else given, inefficient healthcare production implies higher economic cost and lower productivity of the resources deployed in the process. Healthcare productivity varies across health systems of the world countries, the production technologies used, regulatory instruments, and institutional settings. Healthcare production often involves some specific (e.g., drugs and medical devices, information and communication technologies) or general technology for diagnosing, treating, or curing diseases in order to improve or restore human health conditions. In the last half century, the different healthcare systems of the world countries have undergone fundamental transformations in the structural designs, institutional regulations, and socio-economic and demographic dimensions. The nations have allocated a rising share of total economic resources or incomes (i.e., Gross National Product, or GDP) to the healthcare sector and are consequently enjoying substantial increases in population health status and life expectancies. There are complex and interacting linkages among escalating healthcare costs, longer life expectancies, technological progress (or “the march of science”), and sectoral productivities in the health services sectors of the advanced economies. Healthcare policy debates often concentrate on cost-containment strategies and search for improved efficient resource allocation and equitable distribution of the sector’s outputs. Consequently, this contribution is a broad review of the body of literature on technological progress, productivity, and cost: three important dimensions of the evolving modern healthcare systems. It provides a logical integration of three strands of work linking healthcare cost to technology and research evidence on sectoral productivity measurements. Finally, some important aspects of the existing study limitations are noted to motivate new research directions for future investigations to explore in the growing health sector economies.


Sign in / Sign up

Export Citation Format

Share Document